[1] Enoch DA, Yang H, Aliyu SH, et al. The changing epidemiology of Invasive fungal infections[J].Methods Mol Biol, 2017, 1508:17-65. [2] Scriven JE, Tenforde MW, Levitz SM, et al. Modulating host immune responses to fight invasive fungal infections[J].Curr Opin Microbiol, 2017, 40: 95-103. [3] 李云会, 黎 奇, 白劲松, 等. HIV/AIDS 患者侵袭性真菌感染状况及药敏研究[J].皮肤病与性病, 2018,40:168-171. [4] 程卫, 魏俊吉, 王任直, 等. 中枢神经系统真菌感染诊断治疗进展[J]. 基础医学与临床, 2012, 32:358-361. [5] 刘晨瑞, 李亚萍, 冯丹丹, 等. 终末期肝病合并真菌感染诊治的热点与难点[J].世界华人消化杂志, 2020, 28:203-209. [6] 张海平, 杨莉佳, 陶诗沁, 等. 实时荧光PCR检测病原真菌方法的建立及其临床应用[J].基础医学与临床, 2009, 29:1327-1328. [7] 黄永杰, 谢林森, 崔玲玲, 等. 痰真菌培养联合G试验与GM试验对侵袭性真菌感染诊断价值[J].中华医院感染学杂志, 2019,29:3225-3228. [8] 马兴璇, 唐石伏, 阳建伶, 等. (1,3)-β-D-葡聚糖实验干扰因素的研究进展[J].中国当代医药, 2020, 27:21-23. [9] Adachi Y, Ishii M,Kanno T, et al. N-terminal (1→3)-β-d-glucan recognition proteins from insects recognize the difference in ultra-structures of (1→3)-β-d-glucan[J].Int J Mol Sci, 2019, 20:3498-3512. [10] 唐晓丹, 李光辉. 2016年美国感染病学会曲霉病诊断处理实践指南[J].中国抗感染化疗杂志, 2017, 17:456-463. [11] 岳磊, 朱秀梅, 张婷, 等. 重症监护病房患者侵袭性真菌感染情况分析[J].检验医学与临床, 2019, 16:2837-2839. [12] 杨斐, 李红宾, 曹立娟, 等. 医院内侵袭性真菌感染现状[J].皮肤病与性病, 2019, 41:666-669. [13] 李占甲, 翟红岩, 陈水平. G试验在侵袭性真菌病诊断中的最新进展[J].检验医学, 2019, 34:859-863. [14] Anjugam M,Vaseeharan B,Iswarya A, et al. Biological synthesis of silver nanoparticles using β-1, 3 glucan binding protein and their antibacterial, antibiofilm and cytotoxic potential[J].Microb Pathog, 2018, 115:31-40. [15] Tissot F, Lamoth F, Hauser PM, et al.Beta-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis[J].Am J Respir Crit Care Med, 2013, 188:1100-1109. [16] Tran T, Beal SG. Application of the 1,3-beta-D-glucan(Fungitell) assay in the diagnosis of invasive fungal infections[J].Arch Pathol Lab Med, 2016, 140: 181-185. [17] Cohen JF, Ouziel A, Matczak S, et al.Diagnostic accuracy of serum (1,3)-beta-d-glucan for neonatal invasive candidiasis: systematic review and meta-analysis[J].Clin Microbiol Infect, 2020, 26:291-298. |